jupiterneurosciences.com (JUNS) - Uzoq muddatli majburiyatlarning kapitalga nisbati
Jupiter Neurosciences Inc (JUNS) o'zining to'plangan mablag'larini Alzheymer terapiyasi ishlab chiqishga sarflamoqda, bu esa moliyaviy bosimni keltirib chiqarmoqda. GURU.Markets platformasining ushbu kunlik narxlar grafigi uzoq muddatli majburiyatlarning kapitalga nisbatini ko'rsatadi, bunda metrika qiymati 0.00 ni tashkil etadi. Narxlar o'sishi shifokorlar ishtirokidagi avtomatlashtirilgan dori sintezi va JOTROL platformasining noyob bio-mavjudligi bilan qo'llab-quvvatlanmoqda, bu esa kompaniyaga bozorga kirganida to'liq narx belgilash imkoniyatini beradi.
&width=1200&height=400&colorIndex=0&v=mvujvhid.si-7ayy9s0&start=20220704&end=20261029&filename=GURU_Markets_-_JUNS_-_Jupiter-Neurosciences-Inc_-_Long-Term-Debt-to-Equity-Ratio "JUNS - Jupiter Neurosciences Uzoq muddatli qarzning kapitalga nisbati 04.12.2024 - 29.10.2026 oraligʻida | 👁️GURU.Markets👁️")
Jupiter Neurosciences Inc kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Jupiter Neurosciences Inc|JUNS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli kreditlarning kapitalga nisbati Jupiter Neurosciences, Inc.|JUNS - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Jupiter Neurosciences Inc|JUNS - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli majburiyatlar Jupiter Neurosciences|Oraliq qoplama koeffitsiyenti jupiterneurosciences.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:JUNS, jupiterneurosciences.com
Jupiter Neurosciences Inc (JUNS) neyrodegenerativ patologiyalar terapiyasi uchun innovatsion JPC-033 dori vositasini ishlab chiqishga e'tibor qaratadi. Uzoq muddatli qarzning kapitalga nisbati tuzilmasini tahlil qilish R&D bosqichi uchun moliyalashtirish barqarorligini baholash imkonini beradi. Ushbu ko'rsatkich sof aktivlarning umumiy qiymatiga nisbatan muddati bir yildan ortiq bo'lgan kredit majburiyatlarining ulushini belgilaydi. Kredit yuklamasining ortishi kapital daromadlarini oshirishi mumkin, ammo bu foiz xarajatlari xavfini yuqoritadi. Ushbu metrikaning past qiymati kompaniyaning moliyaviy avtonomiyasini tasdiqlaydi.
Raqobatdosh kompaniyalar tahlili
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Denali Therapeutics|HRMY (harmonybiosciences.com) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati BHVN (Biohaven)|Uzoq muddatli qarzning kapitalga nisbati Amylyx Pharmaceuticals Inc (AMLX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Trevi Pharma TRVI|PRAX (Praxis Corp) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Anavex Life Sciences - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati ceribell.com CBLL|PRTA (Prothena Corp) - Uzoq muddatli qarzning o'z kapitaliga nisbati|ALEC: Uzoq muddatli kreditlarning kapitalga nisbati|ANNX (Annexon Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Omeros Corp. OMER|Uzoq muddatli qarzning o'z kapitaliga nisbati Neurogene Inc. (NGNE)|ACIU (acimmune.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Voyager Therapeutics, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti NMRA|SCLX - Uzoq muddatli qarzning o'z kapitaliga nisbati|TVGN (Tevogen Bio Inc.) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|ACOG: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati cogrx.com (CGTX)|Uzoq muddatli qarzning o'z kapitaliga nisbati IKT|Uzoq muddatli qarzning kapitalga nisbati Cassava Sciences Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati Assertio Holdings, Inc. (ASRT)|COYA (coyatherapeutics.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Vistagen VTGN|Ovid Therapeutics Inc (OVID) - Uzoq muddatli majburiyatlarning kapitalga nisbati|ABOS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati CervoMed, Inc. CRVO|ATHE: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Clene|PEPG (PepGen Inc) - Uzoq muddatli qarzning kapitalga nisbati|relmada.com (RLMD) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ANVS|GRCE - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Firefly Neuroscience Inc AIFF|KLTO: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|NeuroSense Therapeutics, Ltd. - Uzoq muddatli qarzning kapitalga nisbati|revivapharma.com (RVPH) - Uzoq muddatli qarzning o'z kapitaliga nisbati|MTVA: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati NeurAxis Inc. (NRXS)|Uzoq muddatli qarzning o'z kapitaliga nisbati Helius Medical Technologies, Inc.|Passage Bio Corp (PASG) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati NEUP (Neuphoria Therapeutics Inc.)|NERV (minervaneurosciences.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ATHA (Athira Pharma)|Uzoq muddatli qarzdorlikning kapitalga nisbati Addex Therapeutics Ltd. (ADXN)|ALZN - Uzoq muddatli qarzning o'z kapitaliga nisbati|CYCN (Cyclerion Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|PTIX: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Pasithea Therapeutics Corp.|Uzoq muddatli qarzning o'z kapitaliga nisbati Cortigent Inc|ATXI (Avenue Therapeutics Inc.) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati BCLI (Brainstorm Cell Therapeutics, Inc.)|Uzoq muddatli qarzning kapitalga nisbati Cara Therapeutics Inc (CARA)|Uzoq muddatli qarzning o'z kapitaliga nisbati Chromocell Therapeutics CHRO|ELYM: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|ITCI - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Longboard Pharmaceuticals Inc LBPH|Marinus (MRNS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi NKGN|NRBO (NeuroBo Pharmaceuticals) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati sagerx.com SAGE|Uzoq muddatli qarzning o'z kapitaliga nisbati SNPX (Synaptogenix)|Uzoq muddatli qarzning kapitalga nisbati Trevena Inc. (TRVN)|Uzoq muddatli qarzning o'z kapitaliga nisbati Vigil Neuroscience, Inc. VIGL|Uzoq muddatli qarzning kapitalga koeffitsiyenti WENA|CERE - Uzoq muddatli qarzning o'z kapitaliga nisbati